65 results
DEFM14A
ISEE
IVERIC bio Inc
5 Jun 23
Proxy related to merger
8:54am
or effect arising from any act of terrorism, war, national or international calamity, natural disaster, acts of god, epidemic, pandemic or any other
PREM14A
ISEE
IVERIC bio Inc
23 May 23
Preliminary proxy related to merger
6:49am
arising from any act of terrorism, war, national or international calamity, natural disaster, acts of god, epidemic, pandemic or any other similar event
DEFA14A
EX-2.1
ISEE
IVERIC bio Inc
1 May 23
Additional proxy soliciting materials
7:05am
arising from any act of terrorism, war, national or international calamity, natural disaster, acts of god, epidemic, pandemic or any other similar event
8-K
EX-2.1
ISEE
IVERIC bio Inc
1 May 23
Astellas Enters into Definitive Agreement
7:02am
arising from any act of terrorism, war, national or international calamity, natural disaster, acts of god, epidemic, pandemic or any other similar event
8-K
EX-99.1
ddzl 0jy0h1sv7whftx5
5 Dec 22
Iveric Bio Announces Pricing of $300 Million Public Offering of Common Stock
7:45am
8-K
ouw4w
5 Dec 22
Iveric Bio Announces Pricing of $300 Million Public Offering of Common Stock
7:45am
424B5
7g0j9o9h3jp4ev25
1 Dec 22
Prospectus supplement for primary offering
4:02pm
424B5
nnt1v9brfjjpdg
30 Nov 22
Prospectus supplement for primary offering
4:11pm
8-K
EX-99.1
l2poxse1b cziu
26 Jul 22
Iveric Bio Reports Second Quarter 2022 Operational Highlights and Financial Results
6:36am
8-K
EX-99.1
x5adjr9 oz90eoa
4 May 22
Iveric Bio Reports First Quarter 2022 Operational Highlights and Financial Results
6:38am
8-K
6tyfb4ulmwoohakjx
25 Mar 22
Other Events
4:34pm
8-K
EX-99.1
09pa3tmkthyd25wfba
24 Feb 22
Iveric Bio Reports Fourth Quarter and Full Year 2021 Operational Highlights and Financial Results
6:40am